Status:
NOT_YET_RECRUITING
Hyperbaric Oxygen Treatment for Necrotizing Fasciitis and Necrotizing Soft Tissue Infections
Lead Sponsor:
Corewell Health West
Conditions:
Necrotizing Fascitis
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The goal of this clinical trial is to learn if hyperbaric oxygen is beneficial in treating necrotizing infections and decreasing rates of morbidity and mortality. This study therefore has two aims: 1...
Detailed Description
Necrotizing fasciitis and necrotizing soft tissue infections are a complicated group of infections dominated largely by polymicrobial infections that rapidly spread through the skin and soft tissues. ...
Eligibility Criteria
Inclusion
- Age: 18 years old
- Patients with documented necrotizing fasciitis or necrotizing soft tissue infection as assessed during initial bedside evaluation, in conjunction with available laboratory values, imaging showing gas in soft tissues consitent with necrotizing infection, or surgical debridement of necrosis of fascia, muscle, and variable levels of soft tissue involvement
- Patient or advocate is able to sign consent
Exclusion
- Pediatric patients
- Pregnant patients
- Patients deemed unlikely to survive or unable to go to surgical debridement
Key Trial Info
Start Date :
November 14 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
November 14 2027
Estimated Enrollment :
160 Patients enrolled
Trial Details
Trial ID
NCT07170020
Start Date
November 14 2025
End Date
November 14 2027
Last Update
September 12 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Corewell Health
Grand Rapids, Michigan, United States, 49503